Option Care Health, Inc. OPCH
Nov 5, 2026, 12:44 PM EST
- YTD
- -0.50%
- 1 year
- +17.06%
- Market cap
- 4.75B
- Revenue (ttm)
- 5.69B
- Profit margin
- 3.68%
- EPS (ttm)
- 1.38
- Shares out
- 149.79M
- P/E ratio
- 22.97
- Forward P/E
- 15.20
- YTD return
- -0.50%
- 1-year return
- +17.06%
- Volume
- 1.75M
- Avg volume
- 3.96M
- Open
- 31.72
- Previous close
- 31.65
- Day's range
- 31.67 – 31.79
- 52-week range
- 18.01 – 36.80
- Beta
- 0.46
- Analysts
- Hold
- Price target
- 30.03 (-5.3%)
- Earnings date
- Feb 23, 2027
2Y +9.38 (+42.03%)
Key statistics
- Enterprise value
- 5.83B
- PEG ratio
- 1.53
- Price / sales
- 0.83
- Price / book
- 3.76
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 1.90%
- Free cash flow
- 256.07M
- Total cash
- 196.78M
- Total debt
- 1.27B
- Return on equity
- 16.00%
- Short % of float
- 6.62%
- 50-day average
- 26.83
- 200-day average
- 26.28
Analyst view
Consensus: hold
- Target (low)
- 23.00
- Target (mean)
- 30.03
- Target (high)
- 33.00
- Strong buy0
- Buy0
- Hold11
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 0.48713.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 0.54 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.4894 | 0.49 | 0.00 | +0.12% |
| Jul 29, 2026 | Jun 30, 2026 | 0.4263 | 0.45 | +0.02 | +5.56% |
| Apr 30, 2026 | Mar 31, 2026 | 0.37 | 0.40 | +0.03 | +8.11% |
| Feb 24, 2026 | Dec 31, 2025 | 0.46 | 0.46 | 0.00 | 0.00% |
| Oct 30, 2025 | Sep 30, 2025 | 0.43 | 0.45 | +0.02 | +4.65% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | UBS | down | Buy | Neutral |
| Oct 7, 2026 | William Blair | down | Outperform | Market Perform |
| Oct 7, 2026 | JP Morgan | down | Overweight | Neutral |
| Oct 7, 2026 | Citizens | down | Market Outperform | Market Perform |
| Oct 7, 2026 | Jefferies | down | Buy | Hold |
| Oct 7, 2026 | Barrington Research | down | Outperform | Market Perform |
About Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- optioncarehealth.com
News
Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU?
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026 Option Care Health Q3 Adj. EPS $0.49 Beats $0.48 Estimate, Sales $1.494B Beat $1.476B Estimate
InfuSystem (NYSE:INFU) versus Option Care Health (NASDAQ:OPCH) Head to Head Review
Are OPCH, PTC, RXO Obtaining Fair Deals for their Shareholders?
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU?
OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its Shareholders
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
Your note
Sign in to keep a note on OPCH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BHATIA PRATEEK | Officer | Stock Award(Grant) | Jul 5, 2026 | 39,795 |
| GOLDING DAVID W | Director | Purchase | Aug 20, 2025 | 116,525 |
| GRASHOFF CHRISTOPHER L | Officer | Stock Award(Grant) | Feb 17, 2026 | 48,558 |
| KRAEMER HARRY M. JANSEN JR. | Director | Stock Award(Grant) | May 19, 2026 | 471,076 |
| RADEMACHER JOHN CHARLES | Chief Executive Officer | Purchase | May 3, 2026 | 695,152 |
| SETHNA MEENAL | Chief Financial Officer | Purchase | May 3, 2026 | 98,337 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.76% | 22,104,863 | 699.62M | Jun 29, 2026 |
| Wellington Management Group, LLP | 7.87% | 11,782,384 | 372.91M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.52% | 8,274,458 | 261.89M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 4.97% | 7,450,698 | 235.81M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.72% | 7,063,747 | 223.57M | Jun 29, 2026 |
| Durable Capital Partners Lp | 4.12% | 6,163,722 | 195.08M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 4.78% | 7,157,244 | 226.53M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.51% | 6,748,598 | 213.59M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 5,330,070 | 168.70M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.32% | 4,979,416 | 157.60M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.76% | 4,132,775 | 130.80M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.41% | 3,604,513 | 114.08M | Jun 29, 2026 |
